Three recent studies demonstrated that JQ-1 synergistically kills AML cells when combining with HDAC inhibitors, chemotherapeutic drugs and FLT3 tyrosine kinase inhibitors.31 We provide the first evidence showing the combination of chaetocin and JQ-1 enhances cytotoxicity. Here, HDAC9 is linked to acute myeloid leukemia.